Hopital Louis Pradel
12
1
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Defining Dosimetric Reference Levels in Computed Tomography Spectral Scanning
Role: collaborator
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Role: collaborator
Regional Anaesthesia in Intensive Care Unit
Role: collaborator
Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle
Role: collaborator
Prospective Evaluation of Programmed Ventricular Stimulation Before Pulmonary Valve Replacement in Patients With Tetralogy of Fallot
Role: collaborator
Diagnosis Accuracy of Hemoconcentration to Detect Hypovolemia During CRRT
Role: lead
Diagnosis Accuracy of Abdominal Compression and Hemoconcentration to Detect Diuretic Induced Fluid Removal Intolerance.
Role: lead
Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation
Role: collaborator
Evolution of the Profile of Infectious Endocarditis in France in 2008 (EI2008)
Role: collaborator
Can Capillary Refill Time Variation During Passive Leg Raising Predict Fluid Responsiveness
Role: lead
Fluid Responsiveness Evaluation by AbdomiNal Compression in Kids Based on the STARLING Concept
Role: lead
BIPAP Vision Versus OPTIFLOW System Comparison in Acute Respiratory Failure After Cardio Thoracic Surgery
Role: collaborator
All 12 trials loaded